Type 1 diabetes and perinatal factors in Catalonia (Spain)

V Borras1, A Freitas, C Castell

  • 1Pediatrics Service, Hospital General de Granollers, Barcelona, Spain Department of Health, Autonomous Government of Catalonia, Barcelona, Spain.

Pediatric Diabetes
|March 30, 2011
PubMed

Insights

Being born large for gestational age (LGA) significantly increases the risk of developing type 1 diabetes. This perinatal factor is the primary identified risk for childhood diabetes in the study.

Area of Science:

  • Perinatal epidemiology
  • Endocrinology
  • Pediatric diabetes research

Background:

  • Type 1 diabetes (T1D) is a significant childhood autoimmune disease.
  • Identifying perinatal risk factors for T1D is crucial for early intervention strategies.
  • Previous research has explored various perinatal influences on T1D development.

Purpose of the Study:

  • To investigate perinatal risk factors associated with the development of type 1 diabetes in infants.
  • To determine if birth weight classification is a significant predictor of T1D onset.

Main Methods:

  • Retrospective case-control study utilizing regional diabetes and newborn screening registers.
  • Analysis of 1530 infants (306 T1D cases, 1224 controls).
  • Variables included birth weight (classified as small, appropriate, or large for gestational age - LGA), sex, maternal age, and feeding type.

Main Results:

  • Infants born large for gestational age (LGA) showed a significantly higher prevalence among type 1 diabetes cases (16.3%) compared to controls (11.3%).
  • Children born LGA had a 1.45 times greater risk of developing type 1 diabetes compared to those with normal or low birth weight.
  • No other studied perinatal factors demonstrated a significant association with T1D development.

Conclusions:

  • Being born large for gestational age (LGA) is a significant, independent perinatal risk factor for developing type 1 diabetes.
  • This finding highlights the importance of monitoring birth weight in the context of T1D risk assessment.
  • Further research may explore the biological mechanisms linking LGA to T1D pathogenesis.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...